- Home
- Research Vendors
- Nexaph

- COAs on file
- 5
- Independently confirmed
- 0
- Median purity
- 99.51%
- At or above market
- 1/4
- Most recent
- 10 Dec
across 1 lab
none on record
▼ 0.17 vs corpus
compounds comparable
9 months ago
nexaph.com · registered 2024 · 2y 4m old · transfer-locked · registry checked 29 Jul 2026Registry detail
- Registered
- 6 May 2024
- Registry expiry
- 6 May 2030
- Record last changed
- 4 Oct 2025
- EPP status
- client transfer prohibited
- Source
- RDAP registry
- First indexed by us
- 3 Jul 2026
Research use only. This vendor supplies peptides for laboratory and research purposes — not for human consumption or therapeutic use. PeptideBase does not endorse or guarantee product quality. Verify third-party lab testing before any research use.
Vendor-supplied · Not verified by PeptideBase
What this vendor publishes about itself, repeated here. Disclosure is not verification; only independent lab results change that.
5 certificates on file, all self-published by the vendor. Median purity 99.51%, against 99.68% across all 928 certificates we score. One of four compounds test at or above their market median. The exception is a BPC-157 lot at 99.40% — 0.32 points below the 99.72% median for that compound.
Evidence provenance
- 5 self-published
- COAs the vendor posted on their own site.
Recorded for completeness. A self-published document doesn't count as confirmed on its own — the document is real, the chain of custody isn't independent.
Purity vs market
4 of 4 results sit within ±0.4 points of their market median.
1 further result is not plotted — no purity figure, or too few market results for that compound to compare against. They appear in the table below.
Lab testing record
Every COA we hold for Nexaph.
How these certificates can be checked
Of the 5 certificates we hold for Nexaph:
- 5Carries a lookup reference
| Panel | Source | Reference | |||||
|---|---|---|---|---|---|---|---|
| BPC-157 | Janoshik Analytical | 10 Dec 25 | 99.40% | −0.32 | — | Self-published | View COA ↗ |
| Janoshik Analytical publishes a report lookup and this certificate carries the reference it needs. No lookup result is recorded. | |||||||
| CJC-1295 (without DAC) | Janoshik Analytical | 19 Nov 25 | 99.28% | −0.30 | — | Self-published | View COA ↗ |
| Janoshik Analytical publishes a report lookup and this certificate carries the reference it needs. No lookup result is recorded. | |||||||
| N-Acetyl Semax | Janoshik Analytical | 19 Nov 25 | 99.51% | not enough market data | — | Self-published | View COA ↗ |
| Janoshik Analytical publishes a report lookup and this certificate carries the reference it needs. No lookup result is recorded. | |||||||
| PT-141 | Janoshik Analytical | 3 Nov 25 | 99.84% | −0.05 | — | Self-published | View COA ↗ |
| Janoshik Analytical publishes a report lookup and this certificate carries the reference it needs. No lookup result is recorded. | |||||||
| GHK-Cu | Janoshik Analytical | 24 Jul 24 | 99.85% | +0.06 | — | Self-published | View COA ↗ |
| Janoshik Analytical publishes a report lookup and this certificate carries the reference it needs. No lookup result is recorded. | |||||||
The lab behind these results
In the vendor's own words
Written by the vendor · Not verified by PeptideBase
Shanghai Nexa Pharma Co specializes in advanced peptide research by providing high-quality peptides intended for research purposes. They emphasize stringent quality control and regulatory compliance to ensure their products meet the highest safety standards for scientific use.
#Testing disclosure
- Publishes COAsVendor-stated
- Yes
- COA accessVendor-stated
- Published on the vendor’s website
- Last observedOur record
- 6 Jul 2026
- Batch numbers shownOur record
- Yes
Research catalog
Add this badge to your website
Profile last updated
Cite this page
Free to reference and republish with attribution to PeptideBase. Choose a format:
PeptideBase. (2026). Nexaph — Research Vendor Profile. Retrieved September 11, 2026, from https://peptidebase.io/research-vendors/nexaph